ScinoPharm Taiwan, Ltd. (1789.TW)
TWD 18.7
(-1.32%)
TWD 18.7
(-1.32%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 3.18 Billion | 3.26 Billion | 2.76 Billion | 3.08 Billion | 2.89 Billion | 3.52 Billion |
| Cost of Revenue | 1.97 Billion | 2.01 Billion | 1.48 Billion | 1.76 Billion | 1.71 Billion | 1.98 Billion |
| Gross Profit | 1.21 Billion | 1.25 Billion | 1.28 Billion | 1.31 Billion | 1.17 Billion | 1.54 Billion |
| Operating Expenses | 901.49 Million | 845.13 Million | 991.74 Million | 941.95 Million | 909.33 Million | 984.18 Million |
| Selling, General and Administrative Expenses | 543.75 Million | 573.87 Million | 685.79 Million | 696.32 Million | 670.96 Million | 670.97 Million |
| Research and Development Expenses | 357.74 Million | 271.26 Million | 305.95 Million | 245.63 Million | 238.37 Million | 313.2 Million |
| Other Expenses | - | 18.25 Million | 835 Thousand | -29.46 Million | 53.88 Million | 12.29 Million |
| Cost and Expenses | 2.87 Billion | 2.85 Billion | 2.47 Billion | 2.7 Billion | 2.62 Billion | 2.96 Billion |
| Operating Income | 314.49 Million | 446 Million | 308.95 Million | 373.45 Million | 320.95 Million | 558.32 Million |
| Interest Expense | 9.14 Million | 7.91 Million | 6.54 Million | 15.16 Million | 55.68 Million | 80.16 Million |
| Income Tax Expense | 61.78 Million | 84.74 Million | 58.81 Million | 76.43 Million | 48.39 Million | 47.56 Million |
| Earnings before Tax | 348.84 Million | 437.96 Million | 302.28 Million | 358.5 Million | 265.05 Million | 490.54 Million |
| Net Income | 287.05 Million | 353.21 Million | 243.47 Million | 282.06 Million | 216.65 Million | 442.97 Million |
| Earnings Per Share Basic | 0.36 | 0.45 | 0.31 | 0.36 | 0.27 | 0.56 |
| Earnings Per Share Diluted | 0.36 | 0.45 | 0.31 | 0.36 | 0.27 | 0.56 |
| Weighted Average Shares Outstanding | 790.73 Million | 790.73 Million | 790.73 Million | 790.73 Million | 790.73 Million | 790.73 Million |
| Weighted Average Shares Outstanding (Diluted) | 792.32 Million | 792.68 Million | 792.28 Million | 792.18 Million | 792.07 Million | 793.08 Million |
| Gross Margin | 0.38 | 0.38 | 0.46 | 0.43 | 0.41 | 0.44 |
| EBIT Margin | 0.26 | 0.27 | 0.25 | 0.25 | 0.25 | 0.28 |
| Profit Margin | 0.09 | 0.11 | 0.09 | 0.09 | 0.07 | 0.13 |
| EBITDA | 819.15 Million | 885.47 Million | 690.49 Million | 766.64 Million | 729.67 Million | 964.23 Million |
| Earnings Before Tax Margin | 0.10 | 0.14 | 0.11 | 0.12 | 0.11 | 0.16 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 724.22 Million | 762.35 Million | 883.22 Million | 3.18 Billion | 1.12 Billion | 659.58 Million |
| Cost of Revenue | 445.23 Million | 494.3 Million | 529.91 Million | 1.97 Billion | 665.48 Million | 428.11 Million |
| Gross Profit | 278.98 Million | 268.05 Million | 353.31 Million | 1.21 Billion | 457.67 Million | 231.47 Million |
| Operating Expenses | 247.15 Million | 196.9 Million | 201.47 Million | 901.56 Million | 267.67 Million | 202.74 Million |
| Selling, General and Administrative Expenses | - | 117.63 Million | 126.58 Million | - | 170.38 Million | 120.64 Million |
| Research and Development Expenses | - | 79.27 Million | 74.96 Million | - | 97.28 Million | 82.1 Million |
| Other Expenses | -247.15 Million | 4.53 Million | -201.47 Million | -10.13 Million | -12.36 Million | 639 Thousand |
| Cost and Expenses | 692.38 Million | 691.21 Million | 731.38 Million | 2.87 Billion | 933.15 Million | 630.85 Million |
| Operating Income | 31.83 Million | 71.14 Million | 151.83 Million | 357.92 Million | 191.44 Million | 42.57 Million |
| Interest Expense | - | 2.02 Million | 2.04 Million | 9.14 Million | 2.09 Million | 2.24 Million |
| Income Tax Expense | 6.83 Million | 15.35 Million | 35.03 Million | 61.78 Million | 33.57 Million | 8.34 Million |
| Earnings before Tax | 33.93 Million | 90.23 Million | 175.05 Million | 348.84 Million | 190.95 Million | 39.06 Million |
| Net Income | 27.1 Million | 74.88 Million | 140.02 Million | 287.05 Million | 157.37 Million | 30.71 Million |
| Earnings Per Share Basic | 0.04 | 0.09 | 0.18 | - | 0.20 | 0.04 |
| Earnings Per Share Diluted | - | 0.09 | 0.18 | - | 0.20 | 0.04 |
| Weighted Average Shares Outstanding | - | 790.73 Million | 777.9 Million | 790.73 Million | 790.73 Million | 790.73 Million |
| Weighted Average Shares Outstanding (Diluted) | - | 791.66 Million | 777.9 Million | 792.32 Million | 792.88 Million | 791.31 Million |
| Gross Margin | 0.39 | 0.35 | 0.40 | 0.38 | 0.41 | 0.35 |
| EBIT Margin | 0.04 | 0.25 | 0.34 | - | 0.27 | 0.24 |
| Profit Margin | 0.04 | 0.10 | 0.16 | 0.09 | 0.14 | 0.05 |
| EBITDA | 31.83 Million | 192.6 Million | 296.44 Million | - | 308.67 Million | 156.05 Million |
| Earnings Before Tax Margin | 0.04 | 0.09 | 0.17 | 0.11 | 0.17 | 0.06 |
6855
KALO
FCONSUMER
7374
5310
1907